| Literature DB >> 28529316 |
Lorenzo Galluzzi1,2, José Manuel Bravo-San Pedro2,3,4,5,6, Beth Levine7,8, Douglas R Green9, Guido Kroemer2,3,4,5,6,10,11.
Abstract
Autophagy is central to the maintenance of organismal homeostasis in both physiological and pathological situations. Accordingly, alterations in autophagy have been linked to clinically relevant conditions as diverse as cancer, neurodegeneration and cardiac disorders. Throughout the past decade, autophagy has attracted considerable attention as a target for the development of novel therapeutics. However, such efforts have not yet generated clinically viable interventions. In this Review, we discuss the therapeutic potential of autophagy modulators, analyse the obstacles that have limited their development and propose strategies that may unlock the full therapeutic potential of autophagy modulation in the clinic.Entities:
Mesh:
Year: 2017 PMID: 28529316 PMCID: PMC5713640 DOI: 10.1038/nrd.2017.22
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694